Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (71-80 of 203) with videos related to

Pageof 21
Sort By:
Clinical Proteomics|March 16, 2018
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Andrea Bileck, Besnik Muqaku, et al.
Cell Reports. Medicine|August 12, 2025
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individualsYasser Morsy, Barbara Hubeli, Patrick Turko, et al.
Cancers|July 2, 2021
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database AnalysisFlorentia Dimitriou, Ramon Staeger, Melike Ak, et al.
Nature Medicine|January 9, 2018
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Plos Biology|February 22, 2022
A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegansEvelyn Lattmann, Ting Deng, Michael Walser, et al.
American Journal of Human Genetics|February 12, 2013
Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinismKaren Grønskov, Christopher M Dooley, Elsebet Østergaard, et al.
Nature|January 11, 2013
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Fernando Salangsang, Allison S Landman, et al.
Non-Coding RNA|November 22, 2022
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5Marina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Pigment Cell & Melanoma Research|September 10, 2020
NRAS<sup>Q61K</sup> melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cellsIshani Banik, Phil F Cheng, Christopher M Dooley, et al.
Non-Coding RNA|January 15, 2021
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in MelanomaMarina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Pageof 21

Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Clinical Proteomics|March 16, 2018
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Andrea Bileck, Besnik Muqaku, et al.
Cell Reports. Medicine|August 12, 2025
The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individualsYasser Morsy, Barbara Hubeli, Patrick Turko, et al.
Cancers|July 2, 2021
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database AnalysisFlorentia Dimitriou, Ramon Staeger, Melike Ak, et al.
Nature Medicine|January 9, 2018
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapyCarsten Krieg, Malgorzata Nowicka, Silvia Guglietta, et al.
Plos Biology|February 22, 2022
A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegansEvelyn Lattmann, Ting Deng, Michael Walser, et al.
American Journal of Human Genetics|February 12, 2013
Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinismKaren Grønskov, Christopher M Dooley, Elsebet Østergaard, et al.
Nature|January 11, 2013
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Fernando Salangsang, Allison S Landman, et al.
Non-Coding RNA|November 22, 2022
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. <i>Non-Coding RNA</i> 2021, <i>7</i>, 5Marina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Pigment Cell & Melanoma Research|September 10, 2020
NRAS<sup>Q61K</sup> melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cellsIshani Banik, Phil F Cheng, Christopher M Dooley, et al.
Non-Coding RNA|January 15, 2021
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in MelanomaMarina Tusup, Phil F Cheng, Ernesto Picardi, et al.
Pageof 21